Skip to main content
IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc. — Investor Relations & Filings

Ticker · IDYA ISIN · US45166A1025 LEI · 549300ULW08F62IJML11 US Manufacturing
Open in API
Filings indexed 466 across all filing types
Latest filing 2019-05-17 Regulatory Filings
Country US United States of America
Listing US IDYA

About IDEAYA Biosciences, Inc.

https://www.ideayabio.com/

IDEAYA Biosciences, Inc. is a clinical-stage precision medicine oncology company focused on the discovery, development, and commercialization of targeted therapeutics for cancer. The company's primary scientific approach is synthetic lethality, an emerging class of precision medicine that targets cancer cells based on specific genetic alterations. IDEAYA develops potential first-in-class and best-in-class therapies for patient populations selected using molecular diagnostics. Its integrated platform combines capabilities in target and biomarker discovery with the development of small molecule and protein degrader therapeutics to address unmet needs in cancer treatment.

Recent filings

Filing Released Lang Actions
8-A12B
Regulatory Filings Classification · 100% confidence The document is a Form 8-A filed with the SEC for registration of certain classes of securities pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934. It describes the registration of common stock on The Nasdaq Stock Market. The document is a regulatory filing related to securities registration, not a financial report, earnings release, or other types of filings like annual reports or management information. It is a formal registration statement, which fits best under the category of Regulatory Filings (RNS) as it does not match any other more specific category and is a compliance document.
2019-05-17 English
S-1/A
Regulatory Filings Classification · 100% confidence The document is a Form S-1/A Registration Statement Amendment No. 1 filed with the SEC for IDEAYA Biosciences, Inc. It is a regulatory filing related to the registration of securities for an initial public offering (IPO). The text includes details about the offering, underwriting, risk factors, management discussion, and financial data, typical of a registration statement prospectus. This is not an annual report, earnings release, or any other financial report but a registration statement amendment under the Securities Act of 1933. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers miscellaneous filings that do not fit other categories, including registration statements and amendments thereto.
2019-05-13 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a detailed correspondence letter from IDEAYA Biosciences, Inc. to the SEC staff regarding a Registration Statement on Form S-1 filed for an IPO. It includes extensive discussion on stock option grants, valuation methodologies, and fair value determinations of common stock, referencing the Registration Statement and confidential treatment requests. The content is focused on the IPO registration process, stock-based compensation, and valuation disclosures rather than a financial report or earnings release. It is not a full financial report like a 10-K or interim report, nor is it a simple announcement or certification. The document is a regulatory correspondence related to the registration and IPO process, which fits best under Regulatory Filings (RNS) as it does not match other specific categories such as Capital/Financing Update (CAP) or Proxy Solicitation (PSI).
2019-05-01 English
S-1
Regulatory Filings Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used by companies to register securities for an initial public offering (IPO). It includes detailed information about the company, its business, management, financial data, risk factors, and the offering itself. The presence of terms like 'Registration Statement', 'Securities Act of 1933', 'initial public offering', and detailed prospectus content confirms this is a registration filing for securities offering, not a financial report or earnings release. According to the filing definitions, this type of document does not fit into categories like Annual Report, Earnings Release, or Capital/Financing Update. It is a regulatory filing related to securities registration. The closest and most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous filings that do not fit other categories, including SEC registration statements like Form S-1.
2019-04-26 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a letter from a law firm to the SEC staff regarding an Amendment No. 2 to a Draft Registration Statement on Form S-1 for IDEAYA Biosciences, Inc. It discusses responses to SEC comment letters and revisions to the Registration Statement. The document is a correspondence related to a registration filing, not the registration statement itself or a financial report. It is a regulatory communication and does not contain financial statements or detailed report content. The document length is 4727 characters, which is relatively short and consistent with a regulatory filing letter. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory correspondence and filings that do not fit other categories.
2019-04-15 English
Capital/Financing Update 2019
Capital/Financing Update Classification · 100% confidence The document is a confidential draft registration statement submitted to the U.S. Securities and Exchange Commission on Form S-1. It is a registration statement under the Securities Act of 1933 for IDEAYA Biosciences, Inc. The document includes a preliminary prospectus for an initial public offering (IPO) of common stock. It contains detailed information about the company, its business, management, financial data, risk factors, and offering details. Form S-1 is a registration statement used for securities offerings, specifically for IPOs and other public offerings. This type of document is related to capital raising activities and financing updates rather than a financial report or earnings release. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement or a certification, but the actual registration statement and prospectus text. Hence, it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2019-04-13 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.